Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Am Coll Surg. 2012 May 24;215(1):126–135. doi: 10.1016/j.jamcollsurg.2012.02.021

Figure 5.

Figure 5

Kaplan-Meier disease-free survival curve. FGS lengthened disease-free survival from 1 week (95% CI, ≥1 week) to 7 weeks (95% CI, ≥3 weeks). By termination date, 70% of the mice in the BLS group had evidence of tumor recurrence based on images obtained with the OV-100 Small Animal Imaging System, while 50% had recurred in the FGS group.